71 Results for "

prostate-specific antigen

" in MedChemExpress (MCE) Product Catalog:
Products (71)

71 Results for "prostate-specific antigen" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-117410
CAS No.: 1702967-37-0
Purity:  99.46%
Synonyms: PSMA-617
Research Areas:  

Cancer

Vipivotide tetraxetan (PSMA-617) is a high potent prostate-specific membrane antigen (PSMA) inhibitor, with a Ki of 0.37 nM. Vipivotide tetraxetan (PSMA-617) is designed consisting of three components: the pharmacophore Glutamate-urea-Lysine, the chelator DOTA able to complex both 68Ga or 177Lu, and a linker connecting these two entities. Glutamate-urea-Lysine is the selective pharmacophore to bind to prostate specific membrane antigen.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12759
CAS No.: 1020399-49-8
Purity:  ≥95.0%
Research Areas:  

Cancer

CARM1-IN-1 (compound 7g) is a highly potent and selective inhibitor of CARM1 (IC50=8.6 μM, CARM1/PABP1), with low inhibitory activity against PRMT1 and SET7 (IC50 >667 μM). CARM1-IN-1 inhibits the methylation activity of CARM1 and the methylation levels of different substrates, such as PABP1, CA150, SmB, and H3. CARM1-IN-1 also inhibits the promoter activity of prostate-specific antigen (PSA) without significant cytotoxicity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12759A
CAS No.: 2070018-31-2
Purity:  95.13%
Research Areas:  

Cancer

CARM1-IN-1 (compound 7g) hydrochloride is a highly potent and selective inhibitor of CARM1 (IC50=8.6 μM, CARM1/PABP1), with low inhibitory activity against PRMT1 and SET7 (IC50 >667 μM). CARM1-IN-1 hydrochloride inhibits the methylation activity of CARM1 and the methylation levels of different substrates, such as PABP1, CA150, SmB, and H3. CARM1-IN-1 hydrochloride also inhibits the promoter activity of prostate-specific antigen (PSA) without significant cytotoxicity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-148761
CAS No.: 2192281-54-0
Purity:  99.67%
Synonyms: PSMA I&T; PNT-2002
Target:  

PSMA

Research Areas:  

Cancer

PSMA I&T is an effective inhibitor of prostate-specific membrane antigen (PSMA). PSMA I&T can be used for SPECT/CT imaging and radionuclide studies in triple-negative breast cancer and prostate cancer (PCa) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125399
CAS No.: 1366302-52-4
Purity:  99.74%
Synonyms: HBED-CC-PSMA
Research Areas:  

Cancer

PSMA-11 is a small molecule ligand that targets prostate-specific membrane antigen (PSMA) and has the ability to inhibit PSMA activity. PSMA-11 can be used to synthesize 68Ga-PSMA-11, a positron emission tomography (PET) tracer that can be used to image advanced prostate cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2908
CAS No.: 4707-47-5
Synonyms: Methyl atrarate
Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103591
CAS No.: 1026987-94-9
Purity:  ≥98.0%
Target:  

PSMA

Research Areas:  

Cancer

DUPA(OtBu)-OH is a DUPA precursor. DUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70266
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuprostate-specific antigen/KLK3, His; prostate-specific antigen; PSA; Gamma-Seminoprotein; Seminin; Kallikrein-3; P-30 antigen; Semenogelase; KLK3; APS
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-43869
CAS No.: 1703768-74-4
Synonyms: PSMA-617 Ligand-Linker Conjugate
Target:  

ADC Linkers

Research Areas:  

Cancer

Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is a complex composed of pharmacophore group Glutamate-urea-Lysine peptide coupling linker, which can be used to synthesize Vipivotide tetraxetan (PSMA-617). Glutamate-urea-Lysine selectively binds to prostate-specific membrane antigen (PSMA) .
loading...
    loading...
Cat. No.: HY-P5990
CAS No.: 380225-52-5
Target:  

PSMA

Research Areas:  

Cancer

Prostate Specific Antigen Substrate is a highly specific fluorescent peptide substrate can be used for measuring prostate-specific antigen (PSA) enzymatic activity .
loading...
    loading...
Cat. No.: HY-20167A
CAS No.: 32677-01-3
Target:  

Neurokinin Receptor

Research Areas:  

Cancer

H-Glu(OtBu)-OtBu hydrochloride is a key intermediate that can be used to synthesize prostate-specific membrane antigen (PSMA) targeting probes. H-Glu(OtBu)-OtBu hydrochloride can reduce nonspecific background binding through negatively charged linkers, improve tumor/background contrast, and can be used in prostate cancer PET/SPECT imaging studies .
loading...
    loading...
Cat. No.: HY-117756
CAS No.: 1423758-00-2
Purity:  99.10%
Synonyms: DCFPYL
Target:  

PSMA

Research Areas:  

Cancer

Piflufolastat (DCFPYL) can be used for the preparation of piflufolastat F 18 (DCFPyL F-18). Piflufolastat F-18 (DCFPyL F-18) is an 18F-labeled imaging agent. Piflufolastat F-18 can be used for positron emission tomography (PET) targeting prostate-specific membrane antigen (PSMA). Piflufolastat can be used for imaging of prostate cancer .
loading...
    loading...
Cat. No.: HY-P99418
CAS No.: 2314491-93-3
Synonyms: AMG-160

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Acapatamab (AMG-160) is an anti-CD3E/FOLH1 monoclonal antibody .
loading...
    loading...
Cat. No.: HY-141729
Purity:  98.77%
Target:  

Fluorescent Dye

Research Areas:  

Cancer

Biotin-NH-PSMA-617 is a biotin-tagged PSMA-617. PSMA-617 is a small molecule targeting the prostate-specific membrane antigen (PSMA), which is directly expressed by the tumor cells .
loading...
    loading...
Cat. No.: HY-147287
CAS No.: 1228927-36-3
Purity:  97.45%
Target:  

PSMA Drug Intermediate

Research Areas:  

Cancer

Glu-urea-Glu-NHS ester is an activated N-hydroxysuccinamide (NHS) ester of Glu-urea-Glu. Glu-urea-Glu-NHS ester can be used for synthesis of small-molecule prostate-specific membrane antigen (PSMA) inhibitors, imaging agents (such as PSMAi-PEG conjugates), and targeted drug delivery vehicles .
loading...
    loading...
Cat. No.: HY-160893
CAS No.: 2374814-84-1
Target:  

PSMA

Research Areas:  

Cancer

PSMA-azide is a prostate-specific membrane antigen (PSMA) ligand. PSMA-azide inhibits PSMA-dependent NAAG (N-acetylaspartylglutamic acid) hydrolysis, with an IC50 of 9 nM and a Ki of 1 nM. PSMA-azide contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups .
loading...
    loading...
Cat. No.: HY-N0475
CAS No.: 74285-86-2
Synonyms: Hypolide; (+)-Triptophenolide
Triptophenolide (Hypolide) is a colorless crystal isolated from the ethyl acetate extract of Tripterygium wilfordii. Triptophenolide is an orally active pan‑antagonist of the androgen receptor (AR) with an IC50 of 467 nM against human wild‑type AR. Triptophenolide reduces AR expression, inhibits AR nuclear translocation, downregulates prostate‑specific antigen mRNA levels, and suppresses the growth of AR‑positive prostate cancer cells. Triptophenolide shows anti-tumor effects against breast cancer by inhibiting cell proliferation and migration, inducing G1-phase arrest and apoptosis, repressing xenograft tumor growth. Triptophenolide inhibits pyroptosis, alleviates tissue inflammation, and ameliorates synovial injury. Triptophenolide can be used for the study of prostate cancer, rheumatoid arthritis and breast cancer .
loading...
    loading...
Cat. No.: HY-W005629
CAS No.: 1446-61-3
Leelamine is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor with an IC50 value of 9.5 μM, showing a blood glucose lowering effect in the diabetic mouse. Leelamine is also a weak agonist of cannabinoid receptors CB1 and CB2. Leelamine decreases mitotic activity, prostate-specific antigen expression and induces Apoptosis to cell death in cancer cells .
loading...
    loading...
Cat. No.: HY-145709
CAS No.: 2230880-25-6
Purity:  98.02%
Target:  

Androgen Receptor

Research Areas:  

Cancer

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. Ar-V7-IN-1 inhibits the transcriptional activity of androgen receptor (AR) and the secretion of prostate-specific antigen (PSA) with an eGFP IC50 of 1232 nM and the PSA IC50 of 1391 μM. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer .
loading...
    loading...
Cat. No.: HY-P5290
CAS No.: 2213408-17-2
Research Areas:  

Cancer

HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as 188Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research . HYNIC-PSMA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
loading...
    loading...